DocWire News Editors

DocwireNews

From conferences to seminars to education, biosimilars seems to be the talk of the town.&nbsp;Biologics have become the fastest growing&nbsp;class of medication and the&nbsp;biosimilar versions of the biologics used to treat rheumatoid arthritis (RA) and cancer&nbsp;will be able to cut healthcare spending drastically.&nbsp;The&nbsp;US Food and Drug Administration has approved nine biosimilar drugs to date&nbsp;&mdash; six of these to be used for&nbsp;rheumatology and other inflammatory diseases. Based on this information, biosimilars is often looked at as the&nbsp;future for rheumatology.&nbsp;However,&nbsp;according to a report by&nbsp;Practical Pain Management,&nbsp;that might not be the case.&nbsp;SOURCE:&nbsp;<a href="https://www.practicalpainmanagement.com/pain/myofascial/biosimilars-rheumatology-how-popular-will-they-be">Practical Pain Management&nbsp;</a>

Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

How Popular Will Biosimilars Be in Rheumatology?

Rheumatology

From conferences to seminars to education, biosimilars seems to be the talk of the town. Biologics have become the fastest growing class of medication and the biosimilar ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe